Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Sun Pharmaceutical Industries

    - PMLiVE

    David Weinreich appointed as Merck’s Global Head of R&D and CMO, Healthcare

    Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

    - PMLiVE

    Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa

    The company is planning to submit regulatory applications for the candidate by the end of the year

    regeneron headquarters

    Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn

    The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study

    - PMLiVE

    Eli Lilly announces $3bn expansion to US injectables manufacturing facility

    The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines

    - PMLiVE

    Sanofi unveils plans to build €1bn insulin production base in China

    The site will focus on serving the insulin medication needs of local diabetic patients

    - PMLiVE

    Common antidiabetic drug metformin found to slow growth of precancerous cells

    The findings suggest that the drug could be used to manage squamous oesophageal cancer risk

    - PMLiVE

    Eli Lilly’s once-weekly insulin candidate shows promise in late-stage diabetes trials

    It is hoped that a once-weekly treatment option could improve adherence rates

    - PMLiVE

    MSD’s Welireg recommended by NICE to treat rare von Hippel-Lindau disease

    Approximately one in every 70,000 people are affected by the tumour-causing genetic disease

    - PMLiVE

    Merck and Daiichi Sankyo to jointly develop T-cell engager in deal worth over $170m

    The partners will evaluate MK-6070 as part of a combination treatment for small cell lung cancer

    - PMLiVE

    Merck and Astellas/Pfizer’s bladder cancer combination receives positive CHMP opinion

    More than 165,000 new cases of bladder cancer are diagnosed in the EU every year

    - PMLiVE

    Merck’s Keytruda combination recommended by NICE for advanced gastric cancer

    More than 6,500 new cases of gastric cancer are diagnosed in the UK every year

    - PMLiVE

    Merck’s investigational RSV monoclonal antibody clesrovimab shown to protect infants

    The respiratory virus accounts for about 30,000 hospitalisations in children under five every year in the UK

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links